Ausgabe 3/2006
Inhalt (11 Artikel)
Nonmedical economic consequences attributable to visual impairment
Antoine Lafuma, Antoine Brezin, Francis Fagnani, Viviane Mimaud, Mounir Mesbah, Gilles Berdeaux
A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany
Stephen M. Beard, Fiona Maciver, Johannes Clouth, Eckart Rüther
The costs of schizophrenia in Spain
Juan Oliva-Moreno, Julio López-Bastida, Rubén Osuna-Guerrero, Angel Luis Montejo-González, Beatriz Duque-González
Problems and costs associated with alcohol and drug abuse in emergency medicine
F.-X. Huber, T. Hackert, P. J. Meeder
Determinants of household health expenditure on western institutional health care
Tin Tin Su, Subhash Pokhrel, Adjima Gbangou, Steffen Flessa
Price regulation and generic competition in the pharmaceutical market
Dag Morten Dalen, Steinar Strøm, Tonje Haabeth
Alcohol-related mortality, drinking behavior, and business cycles
Edvard Johansson, Petri Böckerman, Ritva Prättälä, Antti Uutela
Decision models in the evaluation of psychotropic drugs
Corrado Barbui, Camilla Lintas